IGC Pharma, Inc. (IGC)

IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	24	26	18	48	81	19
Market Cap Growth	45.77%	46.64%	-62.80%	-40.34%	321.48%	-76.60%
Enterprise Value	24	25	14	37	79	4
Last Close Price	0.30	0.40	0.34	0.95	1.79	0.49
Forward PE	-	4.35	4.35	4.35	4.35	4.35
PS Ratio	17.88	19.65	19.78	122.03	90.43	4.73
PB Ratio	3.80	3.61	1.21	2.03	2.48	0.73
P/TBV Ratio	5.52	4.63	1.31	2.11	2.51	0.73
PEG Ratio	-	2.26	2.26	2.26	2.26	2.26
EV/Sales Ratio	19.44	18.91	14.82	93.57	88.35	1.01
Debt / Equity Ratio	0.04	0.05	0.03	0.03	0.03	0.02
Asset Turnover	0.12	0.10	0.04	0.01	0.03	0.13
Inventory Turnover	0.36	0.29	0.15	0.04	0.14	1.76
Quick Ratio	0.21	0.55	1.83	4.53	6.27	6.41
Current Ratio	1.15	1.58	3.41	6.19	9.93	9.13
Return on Equity (ROE)	-115.06%	-116.95%	-59.30%	-52.97%	-29.70%	-24.34%
Return on Assets (ROA)	-54.70%	-45.23%	-32.86%	-29.10%	-16.81%	-13.52%
Return on Capital (ROIC)	-69.70%	-53.12%	-36.25%	-31.25%	-17.87%	-14.12%
Earnings Yield	-36.36%	-49.20%	-63.85%	-31.00%	-10.85%	-37.97%
FCF Yield	-19.40%	-20.20%	-40.83%	-15.89%	-15.11%	-67.82%
Buyback Yield / Dilution	-29.68%	-11.91%	-5.17%	-19.13%	-6.26%	-11.57%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q